349 related articles for article (PubMed ID: 23895130)
1. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
Keutgen XM; Filicori F; Fahey TJ
Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
[TBL] [Abstract][Full Text] [Related]
2. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
3. The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology.
Kouniavsky G; Zeiger MA
J Surg Oncol; 2012 Apr; 105(5):438-43. PubMed ID: 22441894
[TBL] [Abstract][Full Text] [Related]
4. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in predicting thyroid malignancy.
Stang MT; Carty SE
Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
[TBL] [Abstract][Full Text] [Related]
6. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.
Bhatia P; Deniwar A; Friedlander P; Aslam R; Kandil E
Anticancer Res; 2015 Mar; 35(3):1237-41. PubMed ID: 25750270
[TBL] [Abstract][Full Text] [Related]
8. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
9. Decision Making in Indeterminate Thyroid Nodules and the Role of Molecular Testing.
Mitchell J; Yip L
Surg Clin North Am; 2019 Aug; 99(4):587-598. PubMed ID: 31255193
[TBL] [Abstract][Full Text] [Related]
10. A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study.
González HE; Martínez JR; Vargas-Salas S; Solar A; Veliz L; Cruz F; Arias T; Loyola S; Horvath E; Tala H; Traipe E; Meneses M; Marín L; Wohllk N; Diaz RE; Véliz J; Pineda P; Arroyo P; Mena N; Bracamonte M; Miranda G; Bruce E; Urra S
Thyroid; 2017 Aug; 27(8):1058-1067. PubMed ID: 28521616
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous large-needle aspiration biopsy histology of palpable thyroid nodules: technical and diagnostic performance.
Carpi A; Nicolini A; Marchetti C; Iervasi G; Antonelli A; Carpi F
Histopathology; 2007 Aug; 51(2):249-57. PubMed ID: 17650219
[TBL] [Abstract][Full Text] [Related]
12. Clinical diagnostic gene expression thyroid testing.
Steward DL; Kloos RT
Otolaryngol Clin North Am; 2014 Aug; 47(4):573-93. PubMed ID: 25041959
[TBL] [Abstract][Full Text] [Related]
13. [Results of fine needle aspiration biopsy, frozen section diagnosis and definite histological results in thyroid pathology. Report of 163 cases].
Boutin P; Bozorg Grayeli A; Terrada C; Rondini-Gilli E; Mosnier I; Julien N; Bouccara D; Groussard O; Bok B; Sterkers O
Rev Laryngol Otol Rhinol (Bord); 2003; 124(1):59-63. PubMed ID: 12934444
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic usefulness of tumor markers in the thyroid cytological samples extracted by fine-needle aspiration biopsy.
Gómez Sáez JM
Endocr Metab Immune Disord Drug Targets; 2010 Mar; 10(1):47-56. PubMed ID: 20088814
[TBL] [Abstract][Full Text] [Related]
15. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
16. Experience with standardized thyroid fine-needle aspiration reporting categories: follow-up data from 529 cases with "indeterminate" or "atypical" reports.
Nga ME; Kumarasinghe MP; Tie B; Sterrett GF; Wood B; Walsh J; Nguyen H; Whyte A; Frost FA
Cancer Cytopathol; 2010 Dec; 118(6):423-33. PubMed ID: 20945329
[TBL] [Abstract][Full Text] [Related]
17. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
Freitas BC; Cerutti JM
Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
[TBL] [Abstract][Full Text] [Related]
18. Value of Molecular Tests in Cytologically Indeterminate Lesions of Thyroid.
Zhang X
Arch Pathol Lab Med; 2015 Dec; 139(12):1484-90. PubMed ID: 26619020
[TBL] [Abstract][Full Text] [Related]
19. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules.
Ferraz C; Eszlinger M; Paschke R
J Clin Endocrinol Metab; 2011 Jul; 96(7):2016-26. PubMed ID: 21593119
[TBL] [Abstract][Full Text] [Related]
20. Nondiagnostic thyroid fine needle aspiration cytology: outcome in surgical treatment.
Tamez-Pérez HE; Gutiérrez-Hermosillo H; Forsbach-Sánchez G; Gómez-de Ossio MD; González-González G; Guzmán-López S; Tamez-Peña AL; Mora-Torres NE; González-Murillo EA
Rev Invest Clin; 2007; 59(3):180-3. PubMed ID: 17910409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]